SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-006387
Filing Date
2020-02-25
Accepted
2020-02-25 16:06:45
Documents
14
Period of Report
2020-02-25
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K allk-8k_20200225.htm   iXBRL 8-K 44590
2 EX-99.1 allk-ex991_6.htm EX-99.1 226141
3 GRAPHIC gqm01uzujwpv000001.jpg GRAPHIC 16725
  Complete submission text file 0001564590-20-006387.txt   435591

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA allk-20200225.xsd EX-101.SCH 5964
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE allk-20200225_lab.xml EX-101.LAB 19495
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE allk-20200225_pre.xml EX-101.PRE 11629
11 EXTRACTED XBRL INSTANCE DOCUMENT allk-8k_20200225_htm.xml XML 3536
Mailing Address 975 ISLAND DRIVE SUITE 201 REDWOOD CITY CA 94065
Business Address 975 ISLAND DRIVE SUITE 201 REDWOOD CITY CA 94065 650-597-5002
Allakos Inc. (Filer) CIK: 0001564824 (see all company filings)

IRS No.: 454798831 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38582 | Film No.: 20650641
SIC: 2834 Pharmaceutical Preparations